Anilkumar C. Nirvanappa

Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo

Basappa, G. Sethi, S. Rangappa, 2016, PloS one.

Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo

Basappa, G. Sethi, S. Rangappa, 2017, PloS one.

Synthesis and characterization of novel 1,2-oxazine-based small molecules that targets acetylcholinesterase.

Basappa, K. Rangappa, A. Sukhorukov, 2014, Bioorganic & medicinal chemistry letters.

Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo

Basappa, G. Sethi, S. Rangappa, 2016, PloS one.